How Far Are We from Understanding the Genetic Basis of Hashimoto's Thyroiditis?

REFERENCES

• Jaume JC. Chapter 3, Endocrine Autoimmunity. In: Gardner D, Shoback D, editors. Greenspan’ basic & clinical endocrinology. 8th ed. New York: McGraw-Hill; 2007. pp. 59–79.
   Google Scholar
• Staii A, Mirocha S, Todorova-Koteva K, Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state. Thyroid Res 2010;3(1): 11–17.
   PubMedGoogle Scholar
• Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001;2(9):777–780.
   PubMed Web of Science ®Google Scholar
• Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 2003;24(5):694–717.
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Tunbridge WM, French JM, The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995;43(1): 55–68.
   PubMed Web of Science ®Google Scholar
• Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves’ disease: A population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001;86(2):930–934.
   PubMed Web of Science ®Google Scholar
• Hansen PS, Brix TH, Iachine I, The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: A study of healthy Danish twins. Eur J Endocrinol 2006;154(1):29–38.
   PubMedGoogle Scholar
• Ban Y, Greenberg DA, Davies TF, ‘Linkage analysis of thyroid antibody production: Evidence for shared susceptibility to clinical autoimmune thyroid disease. J Clin Endocrinol Metab 2008;93(9):3589–3596.
   PubMedGoogle Scholar
• Hall R, Stanbury JB. Familial studies of autoimmune thyroiditis. Clin Exp Immunol 1967;2( Suppl):719–725.
   Google Scholar
• Tomer Y, Ban Y, Concepcion E, Common and unique susceptibility loci in Graves and Hashimoto diseases: Results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003;73(4):736–747.
   PubMedGoogle Scholar
• Vaidya B, Kendall-Taylor P, Pearce SH. The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab 2002;87(12):5385–5397.
   PubMedGoogle Scholar
• Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves’ and Hashimoto's diseases. Autoimmunity 2003;36(6–7):367–379.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA. Immunogenetics of Hashimoto's thyroiditis. J Autoimmune Dis 2005;2(1):1.
   PubMedGoogle Scholar
• Zeitlin AA, Heward JM, Newby PR, Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves’ disease. Genes Immun 2008;9(4):358–363.
   PubMedGoogle Scholar
• Allahabadia A, Gough SC. The different approaches to the genetic analysis of autoimmune thyroid disease. J Endocrinol 1999;163(1):7–13.
   PubMedGoogle Scholar
• Sakai K, Shirasawa S, Ishikawa N, Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 2001;10(13):1379–1386.
   PubMedGoogle Scholar
• Allen EM, Hsueh WC, Sabra MM, A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: Replication of genetic linkage on chromosome 5q11.2-q14.3. J Clin Endocrinol Metab 2003;88(3):1292–1296.
   PubMedGoogle Scholar
• Alkhateeb A, Stetler GL, Old W, Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002;11(6):661–667.
   PubMedGoogle Scholar
• Tomer Y, Barbesino G, Greenberg DA, Mapping the major susceptibility loci for familial Graves’ and Hashimoto's diseases: Evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 1999;84(12):4656–4664.
   PubMedGoogle Scholar
• Smyth D, Cooper JD, Collins JE, Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004;53(11):3020–3023.
   PubMed Web of Science ®Google Scholar
• Forabosco P, Bouzigon E, Ng MY, Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet 2009;17(2):236–243.
   PubMedGoogle Scholar
• Criswell LA, Pfeiffer KA, Lum RF, Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005;76(4):561–567.
   PubMed Web of Science ®Google Scholar
• Taylor JC, Gough SC, Hunt PJ, A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab 2006;91(2):646–653.
   PubMedGoogle Scholar
• Tomer Y, Barbesino G, Greenberg DA, A new Graves disease-susceptibility locus maps to chromosome 20q11.2. international consortium for the genetics of autoimmune thyroid disease. Am J Hum Genet 1998;63(6):1749–1756.
   PubMedGoogle Scholar
• Eschler DC, Hasham A, Tomer Y. Cutting edge: The etiology of autoimmune thyroid diseases. Clin Rev Allergy Immunol 2011;41(2):190–197.
   PubMedGoogle Scholar
• Stefan M, Jacobson EM, Huber AK, Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem 2011;286(36):31168–31179.
   PubMedGoogle Scholar
• Weetman AP. Autoimmune thyroid disease: Propagation and progression. Eur J Endocrinol 2003;148(1):1–9.
   PubMed Web of Science ®Google Scholar
• Ueda H, Howson JM, Esposito L, Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423(6939):506–511.
   PubMed Web of Science ®Google Scholar
• Hunt PJ, Marshall SE, Weetman AP, Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol (Oxf) 2001;55(4):491–499.
   PubMedGoogle Scholar
• Jacobson EM, Yang H, Menconi F, Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: A genetic, biochemical, and reverse immunological perspective. J Biol Chem 2009;284(49):34231–34243.
   PubMedGoogle Scholar
• Brand O, Gough S, Heward J. HLA , CTLA-4 and PTPN22 : The shared genetic master-key to autoimmunity? Expert Rev Mol Med 2005;7(23):1–15.
   PubMedGoogle Scholar
• Muller-Hilke B, Mitchison NA. The role of HLA promoters in autoimmunity. Curr Pharm Des 2006;12(29):3743–3752.
   PubMedGoogle Scholar
• Ban Y, Davies TF, Greenberg DA, The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): Results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 2002;57(1):81–88.
   PubMedGoogle Scholar
• Ban Y, Davies TF, Greenberg DA, Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves’ disease. Genes Immun 2004;5(3):203–208.
   PubMedGoogle Scholar
• Menconi F, Monti MC, Greenberg DA, Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci U S A 2008;105(37):14034–14039.
   PubMedGoogle Scholar
• Kokaraki G, Daniilidis M, Yiangou M, Major histocompatibility complex class II (DRB1*, DQA1*, and DQB1*) and DRB1*04 subtypes’ associations of Hashimoto's thyroiditis in a Greek population. Tissue Antigens 2009;73(3):199–205.
   PubMedGoogle Scholar
• Jenkins D, Penny MA, Fletcher JA, HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1992;37(2):141–145.
   PubMedGoogle Scholar
• Bogner U, Badenhoop K, Peters H, HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 1992;14(2):155–158.
   PubMed Web of Science ®Google Scholar
• Menconi F, Osman R, Monti MC, Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci U S A 2010;107(39):16899–16903.
   PubMedGoogle Scholar
• Hodge SE, Ban Y, Strug LJ, Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves’ disease. Thyroid 2006;16(4):351–355.
   PubMedGoogle Scholar
• Cooper D, Greenspan F, Ladenson P. Chapter 8, The Thyroid Gland. In: Gardner D, Shoback D, editors. Greenspan's basic & clinical endocrinology. 8th ed. New York: McGraw-Hill; 2007. pp. 209–280.
   Google Scholar
• Siggs OM, Miosge LA, Yates AL, Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 2007;27(6):912–926.
   PubMedGoogle Scholar
• Bottini N, Musumeci L, Alonso A, A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36(4):337–338.
   PubMed Web of Science ®Google Scholar
• Begovich AB, Carlton VE, Honigberg LA, A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75(2):330–337.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Martin F, Huang G, PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004;303(5658):685–689.
   PubMed Web of Science ®Google Scholar
• Zoledziewska M, Perra C, Orru V, Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes. Diabetes 2008;57(1):229–234.
   PubMed Web of Science ®Google Scholar
• Viken MK, Amundsen SS, Kvien TK, Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 2005;6(3):271–273.
   PubMed Web of Science ®Google Scholar
• Kyogoku C, Langefeld CD, Ortmann WA, Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004;75(3): 504–507.
   PubMed Web of Science ®Google Scholar
• Velaga MR, Wilson V, Jennings CE, The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J Clin Endocrinol Metab 2004;89(11):5862–5865.
   PubMed Web of Science ®Google Scholar
• Skorka A, Bednarczuk T, Bar-Andziak E, Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves’ disease in a Polish population: Association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) 2005;62(6):679–682.
   PubMed Web of Science ®Google Scholar
• Skinningsrud B, Husebye ES, Gervin K, Mutation screening of PTPN22: Association of the 1858T-allele with Addison's disease. Eur J Hum Genet 2008;16(8):977–982.
   PubMed Web of Science ®Google Scholar
• Lee YH, Rho YH, Choi SJ, The PTPN22 C1858T functional polymorphism and autoimmune diseases–a meta-analysis. Rheumatology (Oxford) 2007;46(1):49–56.
   PubMed Web of Science ®Google Scholar
• Canton I, Akhtar S, Gavalas NG, A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 2005;6(7):584–587.
   PubMed Web of Science ®Google Scholar
• Dultz G, Matheis N, Dittmar M, The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 2009;19(2):143–148.
   PubMed Web of Science ®Google Scholar
• Wu H, Cantor RM, Graham DS, Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: Increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005;52(8):2396–2402.
   PubMedGoogle Scholar
• Ban Y, Tozaki T, Taniyama M, The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 2005;15(10):1115–1118.
   PubMed Web of Science ®Google Scholar
• Kahles H, Ramos-Lopez E, Lange B, Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol 2005;153(6):895–899.
   PubMed Web of Science ®Google Scholar
• Matesanz F, Rueda B, Orozco G, Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J Neurol 2005;252(8):994–995.
   PubMed Web of Science ®Google Scholar
• Begovich AB, Caillier SJ, Alexander HC, The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 2005;76(1): 184–187.
   PubMedGoogle Scholar
• De Jager PL, Sawcer S, Waliszewska A, Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis. Eur J Hum Genet 2006;14(3):317–321.
   PubMed Web of Science ®Google Scholar
• van Oene M, Wintle RF, Liu X, Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 2005;52(7):1993–1998.
   PubMedGoogle Scholar
• Vang T, Miletic AV, Bottini N, Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007;40(6):453–461.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Hansoul S, Nicolae DL, Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40(8):955–962.
   PubMed Web of Science ®Google Scholar
• Vang T, Congia M, Macis MD, Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37(12):1317–1319.
   PubMed Web of Science ®Google Scholar
• Rieck M, Arechiga A, Onengut-Gumuscu S, Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007;179(7):4704–4710.
   PubMed Web of Science ®Google Scholar
• Arechiga AF, Habib T, He Y, Cutting edge: The PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 2009;182(6):3343–3347.
   PubMedGoogle Scholar
• Zikherman J, Hermiston M, Steiner D, PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J Immunol 2009;182(7): 4093–4106.
   PubMed Web of Science ®Google Scholar
• Carlton VE, Hu X, Chokkalingam AP, PTPN22 genetic variation: Evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005;77(4):567–581.
   PubMed Web of Science ®Google Scholar
• Orru V, Tsai SJ, Rueda B, A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 2009;18(3):569–579.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Rodriguez L, Taib WR, Topless R, The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum 2011;63(2): 365–372.
   PubMed Web of Science ®Google Scholar
• Luo L, Cai B, Liu F, Association of protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T gene polymorphism with susceptibility to autoimmune thyroid diseases: A meta-analysis. Endocr J 2012;59(5):439–445.
   PubMedGoogle Scholar
• Kavvoura FK, Akamizu T, Awata T, Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: A meta-analysis. J Clin Endocrinol Metab 2007;92(8):3162–3170.
   PubMed Web of Science ®Google Scholar
• Nithiyananthan R, Heward JM, Allahabadia A, Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 2002;12(1):3–6.
   PubMedGoogle Scholar
• Heward JM, Allahabadia A, Armitage M, The development of Graves’ disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 1999;84(7):2398–2401.
   PubMedGoogle Scholar
• Donner H, Braun J, Seidl C, Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 1997;82(12):4130–4132.
   PubMed Web of Science ®Google Scholar
• Zaletel K, Krhin B, Gaberscek S, Hojker S. Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients with Hashimoto's thyroiditis. Int J Immunogenet 2006;33(2):87–91.
   PubMedGoogle Scholar
• Zaletel K, Krhin B, Gaberscek S, Association of CT60 cytotoxic T lymphocyte antigen-4 gene polymorphism with thyroid autoantibody production in patients with Hashimoto's and postpartum thyroiditis. Clin Exp Immunol 2010;161(1):41–47.
   PubMedGoogle Scholar
• Bicek A, Zaletel K, Gaberscek S, 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Hum Immunol 2009;70(10):820–824.
   PubMedGoogle Scholar
• Yesilkaya E, Koc A, Bideci A, CTLA4 gene polymorphisms in children and adolescents with autoimmune thyroid diseases. Genet Test 2008;12(3):461–464.
   PubMedGoogle Scholar
• Petrone A, Giorgi G, Mesturino CA, Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 2001;11(2):171–175.
   PubMedGoogle Scholar
• Sahin M, Gursoy A, Erdogan MF. Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis. Int J Immunogenet 2009;36(2):103–106.
   PubMedGoogle Scholar
• Inoue N, Watanabe M, Yamada H, Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J Clin Immunol 2012;32(6): 1243–1252.
   PubMedGoogle Scholar
• Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997;46(5):551–554.
   PubMed Web of Science ®Google Scholar
• Jacobson EM, Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the future. J Autoimmun 2007;28(2–3): 85–98.
   PubMedGoogle Scholar
• Caputo M, Rivolta CM, Mories T, Analysis of thyroglobulin gene polymorphisms in patients with autoimmune thyroiditis. Endocrine 2010;37(3):389–395.
   PubMedGoogle Scholar
• Collins JE, Heward JM, Carr-Smith J, Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J Clin Endocrinol Metab 2003;88(10): 5039–5042.
   PubMed Web of Science ®Google Scholar
• Ban Y, Greenberg DA, Concepcion E, Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A 2003;100(25):15119–15124.
   PubMedGoogle Scholar
• Collins JE, Heward JM, Howson JM, Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. J Clin Endocrinol Metab 2004;89(12):6336–6339.
   PubMedGoogle Scholar
• Ban Y, Tozaki T, Taniyama M, Multiple SNPs in intron 41 of thyroglobulin gene are associated with autoimmune thyroid disease in the Japanese population. PLoS One 2012;7(5):e37501.
   Google Scholar
• Anker R, Steinbrueck T, Donis-Keller H. Tetranucleotide repeat polymorphism at the human thyroid peroxidase (hTPO) locus. Hum Mol Genet 1992;1(2):137.
   PubMedGoogle Scholar
• Pirro MT, De Filippis V, Di Cerbo A, Thyroperoxidase microsatellite polymorphism in thyroid diseases. Thyroid 1995;5(6):461–464.
   PubMedGoogle Scholar
• Belguith-Maalej S, Rebuffat SA, Charfeddine I, SLC26A4 expression among autoimmune thyroid tissues. Immunobiology 2011;216(5):571–578.
   PubMedGoogle Scholar
• Hadj Kacem H, Rebai A, Kaffel N, PDS is a new susceptibility gene to autoimmune thyroid diseases: Association and linkage study. J Clin Endocrinol Metab 2003;88(5):2274–2280.
   PubMedGoogle Scholar
• Hadj-Kacem H, Kallel R, Belguith-Maalej S, SLC26A4 variations among Graves’ hyper-functioning thyroid gland. Dis Markers 2010;29(2):63–69.
   PubMedGoogle Scholar
• Yoshida A, Hisatome I, Taniguchi S, Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab 2009;94(2):442–448.
   PubMedGoogle Scholar
• Tomer Y. Genetic susceptibility to autoimmune thyroid disease: Past, present, and future. Thyroid 2010;20(7):715–725.
   PubMedGoogle Scholar
• Vieland VJ, Huang Y, Bartlett C, A multilocus model of the genetic architecture of autoimmune thyroid disorder, with clinical implications. Am J Hum Genet 2008;82(6):1349–1356.
   PubMedGoogle Scholar
• Terauchi M, Yanagawa T, Ishikawa N, Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese population. J Endocrinol Invest 2003;26(12):1208–1212.
   PubMedGoogle Scholar
• Plenge RM, Padyukov L, Remmers EF, Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005;77(6):1044–1060.
   PubMed Web of Science ®Google Scholar
• Baki M, Akman FE, Vural P, The combination of interleukin-10 -1082 and tumor necrosis factor alpha -308 or interleukin-6 -174 genes polymorphisms suggests an association with susceptibility to Hashimoto's thyroiditis. Int Immunopharmacol 2012;12(4):543–546.
   PubMedGoogle Scholar
• Burek CL, Talor MV. Environmental triggers of autoimmune thyroiditis. J Autoimmun 2009;33(3–4):183–189.
   PubMed Web of Science ®Google Scholar
• Duntas LH. Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 2008;4(8):454–460.
   PubMedGoogle Scholar
• Guarneri F, Carlotta D, Saraceno G, Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid 2011;21(11):1283–1284.
   PubMedGoogle Scholar
• Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010;34(3):J322–J326.
   PubMed Web of Science ®Google Scholar
• Morohoshi K, Takahashi Y, Mori K. Viral infection and innate pattern recognition receptors in induction of Hashimoto's thyroiditis. Discov Med 2011;12(67):505–511.
   PubMed Web of Science ®Google Scholar
• Carle A, Pedersen IB, Knudsen N, Thyroid volume in hypothyroidism due to autoimmune disease follows a unimodal distribution: Evidence against primary thyroid atrophy and autoimmune thyroiditis being distinct diseases. J Clin Endocrinol Metab 2009;94(3):833–839.
   PubMedGoogle Scholar